Key Findings

The study demonstrates the use of ssDNA recombineering to introduce targeted mutations in Lactobacillus reuteri, reducing its intrinsic vancomycin resistance through a single amino acid change in the d-Ala-d-Ala ligase (Ddl) enzyme.